Crossref
Tirzepatide Lowered Blood Pressure in People With Obesity
JAMA · 12.03.2024 · 331 (10) · 821
DOI: 10.1001/jama.2024.0726 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 12.03.2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Blood Pressure, Obesity, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Blood PressureObesityAntihypertensive AgentsHypertensionHumansDiabetes Mellitus, Type 2Gastric Inhibitory PolypeptideGlucagon-Like Peptide-2 ReceptorHypoglycemic AgentsTirzepatide
Substanzen
Gastric Inhibitory PolypeptideGlucagon-Like Peptide-2 ReceptorHypoglycemic AgentsTirzepatideAntihypertensive Agents
Zitieren
APA
Harris, E. (2024). Tirzepatide Lowered Blood Pressure in People With Obesity. JAMA, 331(10), 821. https://doi.org/10.1001/jama.2024.0726
Vancouver
Harris E. Tirzepatide Lowered Blood Pressure in People With Obesity. JAMA. 2024;331(10):821. doi:10.1001/jama.2024.0726
BibTeX
@article{Harris2024,
author = {Harris, Emily},
title = {Tirzepatide Lowered Blood Pressure in People With Obesity},
journal = {JAMA},
year = {2024},
volume = {331},
number = {10},
pages = {821},
doi = {10.1001/jama.2024.0726}
}
EUVIMED